top of page

COVID-19 Tied to Acceleration of Alzheimer's Pathology

DENVER ― Certain plasma biomarkers of neuronal damage and neuroinflammation are markedly elevated in hospitalized COVID-19 patients with neurologic symptoms compared to hospitalized COVID-19 patients without such symptoms, a new study shows.

These results suggest COVID-19 may accelerate Alzheimer's disease (AD) symptoms and pathology, said study investigator Thomas Wisniewski, MD, professor of neurology, pathology, and psychiatry at the New York University Grossman School of Medicine, New York City.

The findings were presented here at the Alzheimer's Association International Conference (AAIC) 2021.

0 views0 comments

Recent Posts

See All


bottom of page